Hans Wildiers

2002–2025 年に発表

168
論文数
25,702
被引用数
84
h 指数
159
i10 指数

被引用数

Hans Wildiers の年別被引用数1986 年: 被引用 1 件1992 年: 被引用 1 件1999 年: 被引用 1 件2003 年: 被引用 2 件2004 年: 被引用 4 件2005 年: 被引用 14 件2006 年: 被引用 25 件2007 年: 被引用 34 件2008 年: 被引用 31 件2009 年: 被引用 40 件2010 年: 被引用 51 件2011 年: 被引用 52 件2012 年: 被引用 102 件2013 年: 被引用 130 件2014 年: 被引用 164 件2015 年: 被引用 151 件2016 年: 被引用 222 件2017 年: 被引用 245 件2018 年: 被引用 226 件2019 年: 被引用 811 件2020 年: 被引用 883 件2021 年: 被引用 915 件2022 年: 被引用 870 件2023 年: 被引用 696 件2024 年: 被引用 1,250 件2025 年: 被引用 699 件2026 年: 被引用 23 件1987〜1991 年は被引用が無いため表示していません1993〜1998 年は被引用が無いため表示していません2000〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,616 件、この内訳の 19.3%中国: 引用元論文 1,218 件、この内訳の 9%イギリス: 引用元論文 831 件、この内訳の 6.1%イタリア: 引用元論文 785 件、この内訳の 5.8%フランス: 引用元論文 596 件、この内訳の 4.4%ドイツ: 引用元論文 589 件、この内訳の 4.4%スペイン: 引用元論文 528 件、この内訳の 3.9%カナダ: 引用元論文 479 件、この内訳の 3.5%ベルギー: 引用元論文 470 件、この内訳の 3.5%オランダ: 引用元論文 454 件、この内訳の 3.4%オーストラリア: 引用元論文 425 件、この内訳の 3.1%日本: 引用元論文 300 件、この内訳の 2.2%
0%19.3%その他 31.4%

分野

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology28.4%
  • Immunology and Microbiology2.5%
  • Engineering0.9%
  • Computer Science0.8%
  • Materials Science0.6%
  • その他3.2%

トピック

  • HER2/EGFR in Cancer Research5.5%
  • Breast Cancer Treatment Studies5%
  • Advanced Breast Cancer Therapies4.3%
  • Frailty in Older Adults3%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Cancer Treatment and Pharmacology2.4%
  • その他77.2%

共著者

全論文

検索で開く
  1. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

    著者: , , , , , , , , , , , , , , , , - Nature Medicine 2021 被引用: 915

  2. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 393

  3. Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Yao, Judith D. Bebchuk, Kiana Keyvanjah, Richard Bryce, Adam Brufsky, for the NALA Investigators - Journal of Clinical Oncology 2020 被引用: 609

  4. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sérgio Lilla, Alisa Alekseenko, Vincent Geldhof, Bram Boeckx, Celia de la Calle Arregui, Giuseppe Floris, Johannes V. Swinnen, Jean‐Christophe Marine, Diether Lambrechts, Vicent Pelechano, Massimiliano Mazzone, Sara Zanivan, Jan Cools, Hans Wildiers, Véronique Baud, Thomas G. P. Grünewald, Uri Ben‐David, Christine Desmedt, Ilaria Malanchi, Sarah‐Maria Fendt - Nature Cancer 2023 被引用: 142

  5. International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,799

  6. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 529

  7. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221

  8. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Wildiers, Xuri Li, Yonglun Luo, Peter Carmeliet - Nature Communications 2022 被引用: 160

  9. MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 683

  10. Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

    著者: , , , , , , , , - The Lancet Oncology 2017 被引用: 523

  11. Cancer and Aging: Two Tightly Interconnected Biological Processes

    著者: , , , - Cancers 2021 被引用: 234

  12. Vascular Endothelial Growth Factor and Angiogenesis

    著者: , , , , , - Pharmacological Reviews 2004 被引用: 1,833

  13. Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 102

  14. Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Ásgerður Sverrisdóttir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E. Davidson, Oskar T. Johannsson, Philippe L. Bédard, Sherene Loi, Susan Knox, David Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandão, Andrea Vingiani, Carmela Caballero, Florentine Hilbers, Lucy Yates, Matteo Benelli, David Venet, Martine Piccart - Cancer Discovery 2021 被引用: 177

  15. Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 248

  16. Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

    著者: , , , , , , , , , , , - npj Breast Cancer 2022 被引用: 84

  17. Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , - The Lancet Oncology 2014 被引用: 716

  18. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 被引用: 144

  19. Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandra Anabel Ostoich, Hans Wildiers, Kevin Punie, Joëlle Collignon, Guy Jérusalem, Andrea Gombos, Giuliano Borges, Pedro Emanuel Rubini Liedke, Marcelle Goldner Cesca, Patrícia Medeiros Milhomem Beato, Laura Testa, Hélio Pinczowski, Liane Rapatoni, Debora de Melo Gagliato Jardim, José Bines, David W. Cescon, Jamil Asselah, Andre Blais, Joanne Yu, Jennifer Friedmann, Cristiano Ferrario, Binghe Xu, Shusen Wang, Qingyuan Zhang, ZeFei Jiang, Zhongsheng Tong, Quchang Ouyang, Jingfen Wang, Tingjing Yao, Yongsheng Wang, Xiaojia Wang, Meili Sun, Hui Li, Shu Wang, Yuan Sheng, Aimin Zang, Zhang Zhanmin, Wenyan Chen, Xian Wang, Zhong Ouyang, Wěi Li, Barbara Pistilli, Thomas Bachelot, Mony Ung, Cristian Villanueva, Delphine Garbay, Anne-Claire Hardy-Bessard, Audrey Mailliez, Stéphanie Bécourt, William Mina, Thomas Decker, Julia Radosa, Andreas Schneeweiß, Michael Braun, Bahriye Aktas, Gábor Rubovszky, Zsuzsanna Pápai, Tibor Csőszi, Yousuf Al-Farhat, Ankit Patel, Vineet Govinda Gupta, Richu Sharma, Chandrakanth Mosale Venkatesha, Shailesh Bondarde, Somnath Roy, Nikhil Ghadyalpatil, Lalit Sen Sharma, Rajani Priya Yedla, Michelino De Laurentiis, Ida Paris ほか 101 名 - Journal of Clinical Oncology 2024 被引用: 140

  20. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 321

  21. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 292

  22. Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eveline De Cuypere, Katarzyna Jerzak, Stephen Chia, Maja Maraldo, Jeanette Rønlev, Eva Brix, Minna Tanner, Johanna Mattson, Riikka Huovinen, Pauline Wimberger, Mattea Reinisch, Hans Tesch, Michael Untch, Peter Fasching, Tjoung-Won Park-Simon, Joke Tio, Michael Braun, Eva Maria Grischke, Frederik Marmé, Marion van Mackelenbergh, John McCaffrey, Michelino De Laurentiis, Michele Caruso, Rossana Berardi, Laura Biganzoli, Vittoria Fotia, Toshinari Yamashita, Junji Tsurutani, Koichiro Tsugawa, Nobumoto Tomioka, Maaike de Boer, Daniel Houtsma, Martin Pilskog, Olav Engebråten, Anna Sætersdal, Piotr Wysocki, Zbigniew Nowecki, Barbara Radecka, Jacek Jassem, Renata Duchnowska, Joana Simões, Fatima Cardoso, Ana Rita Sousa, María Jesús Vidal Losada, Cristina Saura Manich, Joaquin Gavilá Gregori, Maria Pilar Lopez Marti, Manuel Ruiz Borrego, Javier Cortés Castán, Rafael López López, César Rodríguez Sanchez, Encarnación González Flores, Carmen Hinojo González, Purificación Martínez del Prado, Aglaia Schiza, Fredrika Killander, Leif Klint, Lorenzo Rossi, Stefan Aebi, Khalil Zaman, Peter Hall, Carey Anders - Nature Medicine 2024 被引用: 183

  23. Geriatric assessment in the management of older patients with cancer – A systematic review (update)

    著者: , , , , , , - Journal of Geriatric Oncology 2022 被引用: 196

  24. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jenny Chang‐Claude, Dieter Flesch‐Janys, Anja Rudolph, Ursula Eilber, Sabine Behrens, Heli Nevanlinna, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Sofia Khan, Kirsimari Aaltonen, Habibul Ahsan, Muhammad G. Kibriya, Alice S. Whittemore, Esther M. John, Kathleen E. Malone, Marilie D. Gammon, Regina M. Santella, Giske Ursin, Enes Makalic, Daniel F. Schmidt, Graham Casey, David J. Hunter, Susan M. Gapstur, Mia M. Gaudet, W. Ryan Diver, Christopher A. Haiman, Fredrick R. Schumacher, Brian E. Henderson, Loı̈c Le Marchand, Christine D. Berg, Stephen J. Chanock, Jonine D. Figueroa, Robert N. Hoover, Diether Lambrechts, Patrick Neven, Hans Wildiers, Erik Van Limbergen, Marjanka K. Schmidt, Annegien Broeks, Senno Verhoef, Sten Cornelissen, Fergus J. Couch, Janet E. Olson, Emily Hallberg, Celine M. Vachon, Quinten Waisfisz, Hanne Meijers‐Heijboer, Muriel A. Adank, Rob B. van der Luijt, Jingmei Li, Jianjun Liu, Keith Humphreys, Daehee Kang, Ji‐Yeob Choi, Sue K. Park, Keun-Young Yoo, Keitaro Matsuo, Hidemi Ito, Hiroji Iwata, Kazuo Tajima, Pascal Guénel, Thérèse Truong, Claire Mulot, Marie Sanchez, Barbara Burwinkel, Frederik Marmé, Harald Surowy, Christof Sohn, Anna H. Wu ほか 148 名 - Nature Genetics 2015 被引用: 634